The DOI matches its Crossref record; 162 of the 165 references it cites were found in a registry or an index.
Association of metabolic syndrome and chronic kidney disease
Open accessAbstract
The prevalence of kidney disease is increasing rapidly worldwide, reflecting rising rates of obesity, diabetes, and associated metabolic syndrome (MetS). Chronic kidney disease and related comorbidities such as obesity, diabetes, and hypertension place a significant financial burden on healthcare systems. Despite the widespread use of RAAS inhibitors, intensive blood pressure and glycemic control, and newer therapeutic options consisting of sodium/glucose cotransporter-2 (SGLT-2) inhibitors or glucagon-like peptide-1 (GLP-1) receptor agonists, a significant risk of progression to end-stage renal disease remains in the high-risk obese and diabetic population. The MetS is a cluster of cardiovascular risk factors that adversely affect the development and progression of chronic kidney failure. According to the criteria of the World Health Organization, it is defined by visceral adiposity, impaired glucose tolerance or insulin resistance, atherogenic dyslipidemia, raised blood pressure, and microalbuminuria with a albumin-to-creatinine ratio ≥30 mg/g. At molecular level MetS is marked by a proinflammatory state and increased oxidative stress leading to various pathophysiological changes causing endothelial dysfunction and a hypercoagulable state. Because the kidney is a highly vascularized organ, it is especially susceptible for those microvascular changes. Therefore, the MetS and its individual components are associated with the premature development, acceleration, and progressio…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Although the study was not designed to examine mechanism(s) underlying CVD risk reduction in CKM, cardioprotective properties of EPA that offset inflammation and oxidative stress while improving endothelial function may have been operative in this high-risk phenotype [[15], [16], [17], [18]].”
From Icosapent ethyl reduces CVD risk in cardiovascular-kidney-metabolic syndrome: REDUCE-IT CKM (2026) · cites this paper as [17]
Citations
Cites
Alberti, K. G. M. M., Eckel, R. H., Grundy, S. M., Zimmet, P. Z., Cleeman, J. I., Donato, K. A., Fruchart, J.-C., James, W. P. T., Loria, C. M., & Smith, S. C. (2009) · Circulation · doi:10.1161/circulationaha.109.192644 · Cited by 14,860
2018 ESC/ESH Guidelines for the management of arterial hypertension
Williams, B., Mancia, G., Spiering, W., Agabiti Rosei, E., Azizi, M., Burnier, M., Clement, D. L., Coca, A., de Simone, G., Dominiczak, A., et al. (2018) · European Heart Journal · doi:10.1093/eurheartj/ehy339 · Cited by 10,286
The metabolic syndrome—a new worldwide definition
Alberti, K. G. M., Zimmet, P., & Shaw, J. (2005) · The Lancet · doi:10.1016/s0140-6736(05)67402-8 · Cited by 9,352
Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction
McMurray, J. J. V., Solomon, S. D., Inzucchi, S. E., Køber, L., Kosiborod, M. N., Martinez, F. A., Ponikowski, P., Sabatine, M. S., Anand, I. S., Bělohlávek, J., et al. (2019) · New England Journal of Medicine · doi:10.1056/nejmoa1911303 · Cited by 7,140
Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes
Wiviott, S. D., Raz, I., Bonaca, M. P., Mosenzon, O., Kato, E. T., Cahn, A., Silverman, M. G., Zelniker, T. A., Kuder, J. F., Murphy, S. A., et al. (2019) · New England Journal of Medicine · doi:10.1056/nejmoa1812389 · Cited by 6,382
Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy
Perkovic, V., Jardine, M. J., Neal, B., Bompoint, S., Heerspink, H. J. L., Charytan, D. M., Edwards, R., Agarwal, R., Bakris, G., Bull, S., et al. (2019) · New England Journal of Medicine · doi:10.1056/nejmoa1811744 · Cited by 6,189
Dapagliflozin in Patients with Chronic Kidney Disease
Heerspink, H. J. L., Stefánsson, B. V., Correa-Rotter, R., Chertow, G. M., Greene, T., Hou, F.-F., Mann, J. F. E., McMurray, J. J. V., Lindberg, M., Rossing, P., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2024816 · Cited by 5,618
Cardiovascular and renal outcomes with empagliflozin in heart failure
Packer, M., Anker, S. D., Butler, J., Filippatos, G., Pocock, S. J., Carson, P., Januzzi, J., Verma, S., Tsutsui, H., Brueckmann, M., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2022190 · Cited by 5,206
Eslam, M., Newsome, P. N., Sarin, S. K., Anstee, Q. M., Targher, G., Romero-Gomez, M., Zelber-Sagi, S., Wai-Sun Wong, V., Dufour, J.-F., Schattenberg, J. M., et al. (2020) · Journal of Hepatology · doi:10.1016/j.jhep.2020.03.039 · Cited by 4,472
Research works printed but not linked: 4
- World Health O, 1999, Definition, diagnosis and classification of diabetes mellitus and its complications: report of a WHO consultation. Part 1, Diagnosis and classification of diabetes mellitus
- Aihara K, 2010, Transforming growth factor‐β1 as a common target molecule for development of cardiovascular diseases, renal insufficiency and metabolic syndrome, Cardiol Res Pract, 2011
- Scurt FG, 2020, Paradigm shift in understanding acute kidney injury in patients with chronic liver disease: from pathophysiology to defining disease entities, Z Gastroenterol, 58, 254
- McMurray JJV, 2020, Dapagliflozin in patients with heart failure and reduced ejection fraction, Reply N Engl J Med, 382, 973
Cited by
Sorted by citations
Cardiovascular-kidney-metabolic syndrome – An integrative review
Kittelson, K. S., Gasparotto, A., Fillmore, N., & Gomes, R. D. S. (2024) · Progress in Cardiovascular Diseases · doi:10.1016/j.pcad.2024.10.012 · Cited by 102
Metabolic syndrome: epidemiology, mechanisms, and current therapeutic approaches
Hamooya, B. M., Siame, L., Muchaili, L., Masenga, S. K., & Kirabo, A. (2025) · Frontiers in Nutrition · doi:10.3389/fnut.2025.1661603 · Cited by 117
Cao, Y., Wang, W., Xie, S., Xu, Y., & Lin, Z. (2025) · BMC Public Health · doi:10.1186/s12889-024-21131-2 · Cited by 81
Yu, W., Sun, S., Yan, Y., Zhou, H., Liu, Z., & Fu, Q. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1519925 · Cited by 70
Giangregorio, F., Mosconi, E., Debellis, M. G., Provini, S., Esposito, C., Garolfi, M., Oraka, S., KALOUDI, O., Mustafazade, G., Marín‐Baselga, R., et al. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13195880 · Cited by 67
Li, M., Lin, H., Yang, Q., Zhang, X., Zhou, Q., Shi, J., & Ge, F. (2024) · SLEEP · doi:10.1093/sleep/zsae280 · Cited by 61
The Kidney in Obesity: Current Evidence, Perspectives and Controversies
Kounatidis, D. C., Vallianou, N. G., Stratigou, T., Voukali, M., Karampela, Ι., & Dalamaga, Μ. (2024) · Current Obesity Reports · doi:10.1007/s13679-024-00583-y · Cited by 54
Kanbay, M., Güldan, M., Özbek, L., Çöpür, S., Covic, A. S., & Covic, A. C. (2024) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2024.07.014 · Cited by 39
Dhurandhar, Y., Tomar, S., Das, A., Prajapati, J. L., Singh, A. K., Bodakhe, S. H., & Namdeo, K. P. (2025) · Molecular Biology Reports · doi:10.1007/s11033-025-10509-z · Cited by 27
Tain, Y., & Hsu, C. (2024) · Antioxidants · doi:10.3390/antiox13020226 · Cited by 26
Dong, J., Yang, F., Xu, Y., Zhao, Q., Li, X., Liu, T., & Tang, Y. (2025) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.5c04950 · Cited by 17
Sakizlian, D. D. M., Boldeanu, L., Mitrea, A., Clenciu, D., Vladu, I. M., Plasiciuc, A. E. C., Șarla, A. V., Siloşi, I., Boldeanu, M. V., Assani, M.-Z., et al. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26136227 · Cited by 16
Metabolic Syndrome and Insulin Resistance in Romania
Ștefan, A. G., Clenciu, D., Mitrea, A., Vladu, I. M., Timofticiuc, D. C. P., Roşu, M. M., Maria, D. T., Dinu, R., Gheonea, T. C., Vladu, B. E., et al. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26062389 · Cited by 16
Huang, N., Lu, B., Zhu, Z.-Z., Zhu, X., Chen, S., Shu, Z.-Y., Liu, G.-F., Peng, Y., & Li, L. (2024) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s477836 · Cited by 14
Insulin resistance and hyperinsulinaemia in kidney disease: mechanisms and metabolic effects
Zaitoon, H., Abdul‐Ghani, M. A., & DeFronzo, R. A. (2026) · Nature Reviews Nephrology · doi:10.1038/s41581-026-01066-0 · Cited by 17
Data-driven cluster analysis identifies distinct types of cardiovascular-kidney-metabolic syndrome
Yang, M., Su, C., Chang, X., Wang, G., & Liu, J. (2025) · European Journal of Preventive Cardiology · doi:10.1093/eurjpc/zwaf708 · Cited by 11
Li, F., Luo, Y., Li, X., Dai, Y., & Xiang, Q. (2024) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-024-01532-4 · Cited by 9
Breastfeeding and Future Cardiovascular, Kidney, and Metabolic Health—A Narrative Review
Tain, Y., Lin, Y.-J., & Hsu, C. (2025) · Nutrients · doi:10.3390/nu17060995 · Cited by 12
Gut microbiota-derived SCFAs and MetS-related nephropathy
Tian, X., Sun, L., Guo, S., Yuan, L., Zhang, T., Huang, C., He, T., Jiang, Q., & Zeng, Y. (2025) · Frontiers in Nutrition · doi:10.3389/fnut.2025.1561271 · Cited by 11
Shen, N., Lu, S., Kong, Z., Gao, Y., Hu, J., Si, S., Wang, J., Li, J., Han, W., Wang, R., et al. (2024) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-024-01386-w · Cited by 8
Zhu, L., Ruan, X., Wang, J., Yan, Y., Tang, C., & Xu, Y. (2024) · Frontiers in Nutrition · doi:10.3389/fnut.2024.1442274 · Cited by 8
Zhang, B., Chen, H., Yang, R., Jiang, Z., Huang, S., Chen, Z., Liu, C., Wang, L., & Liu, X. (2025) · FEBS Journal · doi:10.1111/febs.17414 · Cited by 8
Lezama, C. A. A., Ramos, J., Eguizábal, D. A. A., Ovando, X. S. S., Villagran, J., & Caiza, C. J. M. (2025) · Cureus · doi:10.7759/cureus.85813 · Cited by 12
Complement anaphylatoxins: Potential therapeutic target for diabetic kidney disease
Ma, J., Yiu, W. H., & Tang, S. C. W. (2024) · Diabetic Medicine · doi:10.1111/dme.15427 · Cited by 10
He, W., Wei, Z., Li, S., Han, S., Ma, J., Wu, L., Lu, D., & Ta, G. (2025) · Pharmaceutical Biology · doi:10.1080/13880209.2025.2543829 · Cited by 7
Kim, Y. J., Bae, Y. S., Chang, Y., & Shin, S. H. (2025) · Nutrients · doi:10.3390/nu17182986 · Cited by 7
Han, Z., Gong, L., Xue, Y., Wang, R., Liu, J., Wang, X., Zhao, W., Liao, H., & Li, R. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1426917 · Cited by 7
Gosav, E. M., Tănase, D. M., Ouatu, A., Buliga-Finiș, O. N., Popescu, D., Dascălu, C. G., Dima, N., Bădescu, M. C., & Rezuș, C. (2025) · Life · doi:10.3390/life15060960 · Cited by 7
Lin, D.-J., Hu, D.-X., Wu, Q., Huang, L.-G., Lin, Z.-H., Xu, J., He, X., & Wu, L. (2025) · Frontiers in Nutrition · doi:10.3389/fnut.2025.1508381 · Cited by 6
Feng, C., Li, X., Fan, Z., Zhang, Z., & Di, J. (2025) · BMJ Open · doi:10.1136/bmjopen-2025-099529 · Cited by 6
Wang, Y., Wang, Y., He, X., & Li, X. (2025) · Frontiers in Endocrinology · doi:10.3389/fendo.2025.1554637 · Cited by 14
Shui, K., Zhang, H., Li, T., Hou, J., Lan, G., Peng, F., Yu, S., Xie, X., Dai, H., & Peng, L. (2025) · BMC Nephrology · doi:10.1186/s12882-025-04307-9 · Cited by 6
The burden of metabolic diseases in the Arab region, 1990–2021
Pan, Z., Fouad, Y., Abaalkhail, F., Hassani, A. A., Altarrah, M. Y., Derbala, M., Abdulla, M., Tahiri, M., Al-Busafi, S. A., Alkhalidi, N., et al. (2025) · Therapeutic Advances in Endocrinology and Metabolism · doi:10.1177/20420188251406531 · Cited by 6
Kachouei, A. A., Kamrani, F., Akhavan, N. S., & Haghighatdoost, F. (2025) · Journal of Health Population and Nutrition · doi:10.1186/s41043-025-00872-9 · Cited by 10
Guo, F.-S., Dou, J., Wang, J.-X., Guo, C. Y., Wu, R., Sun, X.-L., Hu, Y.-W., & Wei, J. (2025) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-025-01671-2 · Cited by 6
Metabolic Syndrome Evolution and Cardio-Kidney-Metabolic Multimorbidity
Wang, Y., Chen, Z., Huo, Z., Qin, H., Fu, P., Wu, K., Zheng, H., Cai, Z., Wu, W., Lan, Y., et al. (2025) · JACC Advances · doi:10.1016/j.jacadv.2025.101778 · Cited by 7
Liu, Q., An, X.-F., Li, L., Zhang, H., & Zuo, Y.-Q. (2025) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s527662 · Cited by 5
Wen, S., Zhou, S., Wang, W., Qiu, X., & Feng, Y. (2025) · Journal of the American Heart Association · doi:10.1161/jaha.125.041978 · Cited by 5
Translational Lifestyle Medicine Approaches to Cardiovascular–Kidney–Metabolic Syndrome
Papadakis, Z. (2025) · Healthcare · doi:10.3390/healthcare14010051 · Cited by 5
Wei, X., Wei, J., Feng, J., Li, C., Zhang, Z., Hu, B., Long, N., & Luo, C. (2024) · European journal of medical research · doi:10.1186/s40001-024-01804-9 · Cited by 5
Haodong, Z., Cheng, J., Chen, J., Wang, Y., Liu, X., & Baoping, C. (2025) · Renal Failure · doi:10.1080/0886022x.2025.2494043 · Cited by 5
El-Dis, G. R. A., Abdelazeez, W. M. A., Suliman, A. A., & Mohammed, D. M. (2025) · Food Bioscience · doi:10.1016/j.fbio.2025.106795 · Cited by 6
Zhao, L., Zhao, C., Wang, Z., Chen, Z., Zheng, H., Ai, S., Tao, J., Li, D., Sun, W., & Wang, Y. (2025) · Renal Failure · doi:10.1080/0886022x.2025.2508295 · Cited by 6
Emerging insights into the role of visceral adipose tissue in diabetic kidney disease
Li, L., Liu, C., & Gu, J. (2025) · Frontiers in Nutrition · doi:10.3389/fnut.2025.1715701 · Cited by 4
Yang, G., Cheng, B., Shen, X., Ding, Y., Zhang, Y., Cheng, Q., Zheng, Y., & Zhao, J. (2025) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2025-005137 · Cited by 4
Li, H., Wang, J., Zhang, T., Lou, P., Xu, L., & Ma, L. (2025) · BMC Public Health · doi:10.1186/s12889-025-24674-0 · Cited by 4
Pu, F., He, R., Wei, Y., Gong, J., Mu, D., Shi, L., & Hu, W. (2025) · Obesity Reviews · doi:10.1111/obr.70064 · Cited by 4
Kiyoyama, H., Tanabe, M., Higashi, M., Kamamura, N., Kawano, Y., Ihara, K., Hideura, K., & Ito, K. (2025) · Abdominal Radiology · doi:10.1007/s00261-025-04834-x · Cited by 4
Comparative proteomic analysis of renal tissue of normotensive and hypertensive rats
Бунеева, О. А., Fedchenko, V. I., Kaloshina, S. A., Zavialova, M. G., Zgoda, V. G., & Medvedev, A. E. (2024) · Biomeditsinskaya Khimiya · doi:10.18097/pbmc20247002089 · Cited by 4
Kong, M.-W., Yu, Y., Wan, Y., Gao, Y., & Zhang, C.-X. (2024) · World Journal of Gastroenterology · doi:10.3748/wjg.v30.i36.4036 · Cited by 4
Cai, X., Wang, D., Wang, J., Ding, C., Li, Y., Zheng, J., & Xue, W. (2024) · Frontiers in Endocrinology · doi:10.3389/fendo.2024.1392466 · Cited by 3
Zhang, F., & Li, W. (2025) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s516687 · Cited by 3
MicroRNAs in metabolic syndrome: Mechanisms, diagnosis, and therapy
Rahman, M. A., Islam, M. M., Islam, M. M., Ripon, M. A. R., & Hossain, M. S. (2025) · Advances in clinical chemistry · doi:10.1016/bs.acc.2025.06.003 · Cited by 4
Huang, S.-C., Yao, X., Chen, X.-Q., Chen, X., Li, Y.-X., Kanwar, Y., Chan, F., Ye, P., & Zhan, M. (2024) · Diabetes, Metabolic Syndrome and Obesity : Targets and Therapy · doi:10.2147/dmso.s473299 · Cited by 4
Huang, Y., Fu, R., Zhang, J., Zhou, J., Chen, S., Lin, Z., Xie, X., & Hu, Z. (2025) · BMC Endocrine Disorders · doi:10.1186/s12902-025-01958-5 · Cited by 3
Endocrine disorders linked to chronic kidney disease: Mechanisms and clinical implications
Concepción‐Zavaleta, M. J., Fuentes‐Mendoza, J. M., López-Ramírez, E. P., Martínez-García, J. A., Urteaga, L. A. C., & Paz‐Ibarra, J. (2026) · World Journal of Nephrology · doi:10.5527/wjn.v15.i1.113875 · Cited by 3
Wang, B., Zuo, L., Fan, J., Ji, Y., Xu, L., Xu, M. Q., An, Y., Zhang, Y., Ji, G., & Yu, D. (2024) · Insights into Imaging · doi:10.1186/s13244-024-01722-8 · Cited by 3
Association Between Metabolic Syndrome and the Size of Renal Cysts: A Cross-Sectional Study
Tao, B., Gu, D., Wang, K., Li, Y., Xu, X., & Chen, J. (2024) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s479665 · Cited by 3
Li, W., Chen, L., Jiang, L., Zhang, Z., & Song, K. (2025) · Frontiers in Medicine · doi:10.3389/fmed.2025.1589173 · Cited by 2
Association of predicted basal metabolic rate and insulin resistance in a Chinese general population
Wang, L., Lu, T., Wu, P., Chen, K., & Yi-ming, M. (2025) · BMC Endocrine Disorders · doi:10.1186/s12902-025-01976-3 · Cited by 2
Xu, Y., Zhang, X., Fang, J., Xu, W., Chen, Q., Zhu, Y., Hu, H., Cao, X., & Zhang, X. (2025) · Frontiers in Public Health · doi:10.3389/fpubh.2025.1652015 · Cited by 2
Chen, J., Yang, J., Lu, X., Peng, J., He, L., Tan, W., Yu, Q., & Wang, Y. (2025) · BMC Medical Informatics and Decision Making · doi:10.1186/s12911-025-03248-5 · Cited by 2
Pu, F., He, R., Wei, Y., Li, J., Liao, X., Shi, L., & Hu, W. (2025) · British Journal Of Nutrition · doi:10.1017/s0007114525105801 · Cited by 2
Saad, K. M., Gad, M. S., Tang, J., Capehart, K. L., Abdelsayed, R. A., Williams, J. M., & Elmarakby, A. A. (2025) · Biomedicines · doi:10.3390/biomedicines13123105 · Cited by 2
Inflammatory Load Across Diabetes Duration: CRP and ESR Patterns and Their Metabolic Correlates
Brata, R. D., Vesa, C. M., Moisi, M. I., Ghitea, T. C., Pop, N. O., & Pantiș, C. (2026) · Metabolites · doi:10.3390/metabo16030202 · Cited by 2
Tain, Y., & Hsu, C. (2026) · Biomedical Journal · doi:10.1016/j.bj.2026.100970 · Cited by 2
Alkouri, O. A., Al-Qerem, W. A., Jarrah, M., Alharbi, G., Alrida, N. A., Alabkal, R. M., Hammoudeh, A. J., Abdelgawad, M. E., Alshehri, A., Hasan, A. Y., et al. (2026) · Journal of Cardiovascular Development and Disease · doi:10.3390/jcdd13060240 · Cited by 2
Soares, A. O., Loli, D. A. C., de Carvalho, G. R., Delfino, V. D. A., & Bignardi, P. R. (2026) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-026-10059-0 · Cited by 2
The relationship between cardiometabolic Index and diabetic kidney disease in people with diabetes
Kong, J., Tao, W., Sun, Y., Xu, Y., Li, H., & Li, J. (2025) · Frontiers in Endocrinology · doi:10.3389/fendo.2024.1376813 · Cited by 2
Worldwide impact of disease attributable to low physical activity for diabetes and kidney diseases
Ding, P., Qi, L., Wang, J.-L., Tang, M., & Weng, Y. (2025) · Frontiers in Endocrinology · doi:10.3389/fendo.2025.1499381 · Cited by 2
Guo, Q., Chen, M., Yu, Y., Li, P., Huang, X., Shen, L., Long, C., Liu, X., Lin, T., He, D., et al. (2024) · Pediatric Discovery · doi:10.1002/pdi3.93 · Cited by 1
Matsuoka‐Uchiyama, N., Uchida, H. A., Asakawa, T., Sakurabu, Y., Katayama, K., Okamoto, S., Onishi, Y., Tanaka, K., Takeuchi, H., Takemoto, R., et al. (2025) · Clinical and Experimental Nephrology · doi:10.1007/s10157-025-02640-9 · Cited by 1
Pajareya, P., Chuanchai, W., Siranart, N., Phutinart, S., Jansem, P., Basch, N., Techasatian, W., Tokavanich, N., Prasitlumkum, N., & Chokesuwattanaskul, R. (2025) · Metabolic Syndrome and Related Disorders · doi:10.1089/met.2025.0028 · Cited by 1
Sha, Y., Lu, J., Jin, R., Li, L., & Zhang, M. (2025) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s527941 · Cited by 1
Zeng, Z., & Xiao, Z. (2025) · BMC Public Health · doi:10.1186/s12889-025-23868-w · Cited by 1
Impactos da obesidade na função renal: uma análise das evidências
Cunha, P. A. R., Moreno, A. L., Alvim, A. L. S., & de Oliveira, A. A. S. B. (2025) · Journal Archives of Health · doi:10.46919/archv6n3-007 · Cited by 1
Lyu, Y. S., Yoon, Y., Kim, J. H., & Kim, S. Y. (2025) · Biomedicines · doi:10.3390/biomedicines13081886 · Cited by 1
Shi, L., Zhang, D., & Zhang, S. (2025) · Frontiers in Nutrition · doi:10.3389/fnut.2025.1564368 · Cited by 1
The interplay of NAD+, hyperuricemia, and renal damage: A scientific review
Sánchez‐Lozada, L. G., García‐Arroyo, F. E., Gonzaga, G., Aparicio‐Trejo, O. E., Cuevas-López, B., Reyes-Leo, M., Rodríguez‐Iturbe, B., & Johnson, R. J. (2025) · Pathology - Research and Practice · doi:10.1016/j.prp.2025.156256 · Cited by 1
Peng, X., Chen, S., Wu, S., Ding, X., Wu, K., Huang, Z., Song, Q., Liu, Y., Zhao, M., Olsen, M. H., et al. (2025) · Journal of the American Heart Association · doi:10.1161/jaha.125.041962 · Cited by 1
Yang, H., Huang, Y., Jiang, G., Guo, H., & Duan, Z. (2026) · Nutrition & Metabolism · doi:10.1186/s12986-026-01095-3 · Cited by 1
Gut dysbiosis in kidney injury: therapeutic potential of fecal microbiota transplantation
Liu, J., Ning, X., Yuan, J., Yu, Z., Qin, Y., Xing, Y., Zhao, J., & Sun, S. (2026) · European journal of medical research · doi:10.1186/s40001-026-04100-w · Cited by 1
Cherney, D. Z. I., Rossing, P. R., Canziani, M. E., Caramori, M. L., Correa‐Rotter, R., Cronin, L., Hugo, C., Ji, B., Meyerhoff, J., Nangaku, M., et al. (2026) · Diabetes Obesity and Metabolism · doi:10.1111/dom.70836 · Cited by 1
Metabolic Associated Chronic Kidney Disease
Sharma, S., Kalra, S., Kapoor, N., Anandh, U., Verma, H., & Haddiya, I. (2026) · Indian Journal of Nephrology · doi:10.25259/ijn_524_2025 · Cited by 1
Emerging roles of SIRT7 in metabolic homeostasis and related disorders
Yu, S., Rabiu, L., Zhu, W., & Tian, Y. (2026) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2026.168343 · Cited by 1
Ren, L., Ju, F., Liu, S. J., Cai, Y., Gang, X., & Wang, G. (2024) · Drug Design Development and Therapy · doi:10.2147/dddt.s476815 · Cited by 4
Zhou, H., Huang, H., Zhao, H., Pang, N., Huang, M., Ou, C., & Ming, L. (2025) · BMC Gastroenterology · doi:10.1186/s12876-025-04440-7 · Cited by 1
Pecháňová, O., Bulkova, R., Vranková, S., Klimentova, J., Galandakova, Z., & Cebová, M. (2025) · Physiological Research · doi:10.33549/physiolres.935724 · Cited by 1
Icosapent ethyl reduces CVD risk in cardiovascular-kidney-metabolic syndrome: REDUCE-IT CKM
Miller, M., Bhatt, D. L., Brinton, E. A., Jacobson, T. A., Steg, P. G., Ketchum, S. B., Pineda, A. L., Tardif, J.-C., & Ballantyne, C. M. (2026) · American Journal of Preventive Cardiology · doi:10.1016/j.ajpc.2025.101387
Ren, J., Sun, X., Pei, H., Zhu, S., Zhang, Y., Wen, R., Zhang, X., Liu, J., & Ma, Y. (2023) · doi:10.2196/preprints.54849
Zeng, Z., & Xiao, Z. (2024) · Research Square · doi:10.21203/rs.3.rs-4212743/v1
Ersoy, A., Ersözen, M. E., Ersoy, C., & Sarandöl, E. (2024) · Uludağ Üniversitesi Tıp Fakültesi Dergisi · doi:10.32708/uutfd.1588548
Síndrome metabólico en el paciente renal. Revisión bibliográfica
Hurtado, A. J. M., Cuenca, C. M., Rodríguez, R. E., & Montero, R. C. (2024) · Enfermería Nefrológica · doi:10.37551/s2254-28842024029
Sharma, S., Sharma, A., & Tejpal, S. (2025) · Journal for Research in Applied Sciences and Biotechnology · doi:10.55544/jrasb.4.1.16
The possibility of surgical treatment of urolithiasis in patients with chronic kidney disease
Popov, S. V., Guseinov, R. G., Сивак, К. В., Lelyavina, Т. А., Bunenkov, N. S., & Beshtoev, A. H. (2025) · Nephrology (Saint-Petersburg) · doi:10.36485/1561-6274-2025-29-1-35-45
Kavrakova, J. B., Bogdanska, J., Cekovska, S., Topuzovska, S., Labudovikj, D., Trajkovska, K. T., Kostovska, I., Ampova, H., Emin, M., Petkovska, L., et al. (2025) · Journal of Morphological Sciences · doi:10.55302/jms258126bk
Gambin, D. J., Dallepiane, F. G., Saraiva, L. M., Führ, M. C. S., Piovesan, F., Mirek, C., Carli, J. P. D., & Trentin, M. S. (2025) · Sao Paulo Medical Journal · doi:10.1590/1516-3180.2024.0144.r1.14042025
Metabolic Syndrome and Its Effects on the Reno-Vascular System
Balaji, N., Ayazo, C., & Umana, I. E. (2025) · IntechOpen eBooks · doi:10.5772/intechopen.1011526
Jansana, M. D. M., López, P. J. T., Miquel, J. J. G., López‐González, Á. A., Sbert, P. R., Busquets-Cortés, C., & Ramírez‐Manent, J. I. (2025) · Medical Sciences · doi:10.3390/medsci13030122
Metadata
- Authors
- Scurt, F. G., Ganz, M. J., Herzog, C., Bose, K., Mertens, P. R., & Chatzikyrkou, C.
- Affiliations
- University Clinic for Nephrology and Hypertension, Diabetology and Endocrinology (DE)
- Klinikum Magdeburg (DE)
- Medizinische Hochschule Hannover (DE)
- Corresponding author
- Scurt, Florian G.
- Venue
- Obesity Reviews
- Publisher
- Wiley
- Published
- 2023-10-02
- Volume
- 25
- Issue
- 1
- Pages
- e13649-e13649
- ISSN
- 1467-7881 (ISSN-L)
- 1467-789X
- OpenAlex
- W4387246542
- Cited by
- 155
- References
- 165
- Citations by year
- 2026: 50 · 2025: 75 · 2024: 29 · 2023: 1
- FWCI
- 6.77
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Obesity Reviews (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Nephrology › Chronic Kidney Disease and Diabetes
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Keywords
- metabolic syndrome, chronic kidney disease, obesity, diabetes mellitus, insulin resistance, microalbuminuria, endothelial dysfunction, oxidative stress, inflammation, end-stage renal disease, renal hemodynamics, renal metabolism, SGLT2 inhibitors, GLP-1 receptor agonists, renin-angiotensin system inhibitors
- MeSH terms
- Diabetes Mellitus, Humans, Insulin Resistance, Obesity, Metabolic Syndrome, Renal Insufficiency, Chronic
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
